Recordati Publishes Voting Summary from 29 April 2026 Shareholders’ Meeting

An announcement from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.

Recordati has announced that the summary report of the votes on resolutions approved at its Ordinary and Extraordinary Shareholders’ Meeting held on 29 April 2026 is now available to investors. The report can be consulted on the company’s website in the shareholders’ information section and through the authorized storage mechanism 1INFO, supporting transparency and regulatory compliance for stakeholders.

The publication of the voting summary provides shareholders and market participants with formal insight into the outcomes of the recent meeting’s decisions. This step reinforces Recordati’s corporate governance practices and offers greater visibility on shareholder engagement around the company’s strategic and capital decisions.

The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica is an international pharmaceutical group listed on Borsa Italiana, with origins in a family-run pharmacy in Northern Italy in the 1920s. The company offers treatments in specialty and primary care as well as rare diseases, with fully integrated operations from clinical development to production, commercialization and licensing across about 150 countries in EMEA, the Americas and APAC.

Average Trading Volume: 385,912

Technical Sentiment Signal: Strong Buy

Current Market Cap: €10.14B

See more insights into REC stock on TipRanks’ Stock Analysis page.